AB001
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AB001, covering 2016-08-30 to 2026-04-07. Get the full timeline:
Most recent: Clinical Trial Update: Study of Alpha Radioligand Therapy AB001 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) [Phase 1]